Revive Therapeutics plans up to $1M private placement
Seeking Alpha ·
Revive Therapeutics ( RVVTF ) plans a private placement to raise up to ~$1M. The offering consists of up to 31.25M units priced at $0.032 per unit. Each unit includes one common share and one warrant. Each warrant allows the purchase of one common share at $0.05 for 36 months after closing. The company intends to use the gross proceeds for working capital. Financial information for Revive Therapeutics
DYAX Investor Sentiment
Bullish (Long) 55% · Bearish (Short) 45%
362 participants
Related News
- Lantheus receives Complete Response Letter for LNTH-2501
- Why Braze Stock Jumped Today
- dLocal is set to join the small-cap Russell 2000 index, eyes liquidity boost
- GameStop sees adj. EBITDA above $600M for FY ending Jan. 2027
- Matinas BioPharma faces NYSE notice over equity shortfall; gets until 2027 to comply
- If the Market Stumbles, These Are the Financial Stocks Worth Buying